{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T07:21:20Z","timestamp":1768807280701,"version":"3.49.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,2,13]],"date-time":"2024-02-13T00:00:00Z","timestamp":1707782400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,2,13]],"date-time":"2024-02-13T00:00:00Z","timestamp":1707782400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Ophthalmol"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Objective<\/jats:title>\n                <jats:p>To evaluate the alterations in retrobulbar color Doppler imaging (CDI) parameters and retinal\/choroidal optical coherence tomography angiography (OCTA) parameters and their association with the clinical activity and severity in thyroid-associated orbitopathy (TAO) patients.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>In this study, the retrobulbar flow parameters including resistance index (RI), Pulsatile Index(PI), peak systolic velocity (PSV) and end diastolic velocity (EDV) in posterior ciliary artery (PCA), central retinal artery (CRA) and ophthalmic artery (OA) were determined by CDI. Moreover, the retina and choroidal vascularity including the superficial vessel density (SVD), deep vessel density (DVD), choroidal thickness (ChT) and choroidal vascularity, including total choroidal area (TCA), luminal area (LA), stromal area (SA) and Choroidal Vascularity Index (CVI), were determined by OCTA. All patients grouped as active TAO and inactive TAO based on Clinical activity score (CAS). We picked the severe eye among the subjects and compared all parameters between two groups. We analyzed the correlations among those parameters.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>There was a significant difference in CAS score, proptosis value, ChT, LA, CVI between patients with active TAO and inactive TAO. In the active group, PSV and EDV of PCA were significantly higher than the inactive group. On logistic regression analysis, CAS was closely associated with PSV-PCA. On multiple linear regression, proptosis value was closely associated with ChT, LA, SA and CVI.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Choroidal vascularization and retrobulbar blood flow were concurrently higher in active TAO patients and several variables in choroid circulation was closely related to TAO clinical features.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12886-024-03308-w","type":"journal-article","created":{"date-parts":[[2024,2,13]],"date-time":"2024-02-13T09:03:27Z","timestamp":1707815007000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Correlation between choroidal vascularity and retrobulbar ocular blood flow changes and thyroid-associated ophthalmopathy activity: a cross-sectional study"],"prefix":"10.1186","volume":"24","author":[{"given":"Xinghong","family":"Sun","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mengru","family":"Su","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaowen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haiyun","family":"Shen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhenggao","family":"Xie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wentao","family":"Kong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6893-0616","authenticated-orcid":false,"given":"Dandan","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,2,13]]},"reference":[{"issue":"5","key":"3308_CR1","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1007\/s00417-020-04616-9","volume":"258","author":"C Del Noce","year":"2020","unstructured":"Del Noce C, et al. Evaluation of choroidal thickness and choroidal vascular blood flow in patients with thyroid-associated orbitopathy (TAO) using SD-OCT and Angio-OCT. Graefes Arch Clin Exp Ophthalmol. 2020;258(5):1103\u20137.","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"5","key":"3308_CR2","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1530\/eje.0.1480491","volume":"148","author":"MF Prummel","year":"2003","unstructured":"Prummel MF, et al. Multi-center study on the characteristics and treatment strategies of patients with Graves\u2019 orbitopathy: the first European Group on Graves\u2019 Orbitopathy experience. Eur J Endocrinol. 2003;148(5):491\u20135.","journal-title":"Eur J Endocrinol"},{"key":"3308_CR3","doi-asserted-by":"publisher","first-page":"7453260","DOI":"10.1155\/2019\/7453260","volume":"2019","author":"D \u0141acheta","year":"2019","unstructured":"\u0141acheta D, et al. Immunological Aspects of Graves\u2019 Ophthalmopathy. Biomed Res Int. 2019;2019:7453260.","journal-title":"Biomed Res Int"},{"key":"3308_CR4","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.exer.2015.02.007","volume":"142","author":"WA Dik","year":"2016","unstructured":"Dik WA, Virakul S, van Steensel L. Current perspectives on the role of orbital fibroblasts in the pathogenesis of Graves\u2019 ophthalmopathy. Exp Eye Res. 2016;142:83\u201391.","journal-title":"Exp Eye Res"},{"key":"3308_CR5","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s40662-014-0009-8","volume":"1","author":"C McAlinden","year":"2014","unstructured":"McAlinden C. An overview of thyroid eye disease. Eye Vis (Lond). 2014;1:9.","journal-title":"Eye Vis (Lond)"},{"issue":"7","key":"3308_CR6","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1111\/ceo.13525","volume":"47","author":"FHP Lai","year":"2019","unstructured":"Lai FHP, et al. Choroidal thickness in thyroid-associated orbitopathy. Clin Exp Ophthalmol. 2019;47(7):918\u201324.","journal-title":"Clin Exp Ophthalmol"},{"issue":"2","key":"3308_CR7","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1097\/WNO.0000000000000132","volume":"34","author":"SJ Shan","year":"2014","unstructured":"Shan SJ, Douglas RS. The pathophysiology of thyroid eye disease. J Neuroophthalmol. 2014;34(2):177\u201385.","journal-title":"J Neuroophthalmol"},{"issue":"11","key":"3308_CR8","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.1007\/s00417-009-1144-0","volume":"247","author":"O Konuk","year":"2009","unstructured":"Konuk O, et al. Intraocular pressure and superior ophthalmic vein blood flow velocity in Graves\u2019 orbitopathy: relation with the clinical features. Graefes Arch Clin Exp Ophthalmol. 2009;247(11):1555\u20139.","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"7","key":"3308_CR9","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1038\/eye.2016.93","volume":"30","author":"B \u00d6zkan","year":"2016","unstructured":"\u00d6zkan B, et al. Choroidal changes observed with enhanced depth imaging optical coherence tomography in patients with mild Graves orbitopathy. Eye (Lond). 2016;30(7):917\u201324.","journal-title":"Eye (Lond)"},{"issue":"5","key":"3308_CR10","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/j.survophthal.2012.12.001","volume":"58","author":"S Mrejen","year":"2013","unstructured":"Mrejen S, Spaide RF. Optical coherence tomography: imaging of the choroid and beyond. Surv Ophthalmol. 2013;58(5):387\u2013429.","journal-title":"Surv Ophthalmol"},{"issue":"12","key":"3308_CR11","doi-asserted-by":"publisher","first-page":"1573","DOI":"10.1038\/eye.2016.184","volume":"30","author":"A Sadeghi-Tari","year":"2016","unstructured":"Sadeghi-Tari A, et al. Effect of smoking on retrobulbar blood flow in thyroid eye disease. Eye (Lond). 2016;30(12):1573\u20138.","journal-title":"Eye (Lond)"},{"issue":"8","key":"3308_CR12","doi-asserted-by":"publisher","first-page":"5612","DOI":"10.1167\/iovs.10-6907","volume":"52","author":"M P\u00e9rez-L\u00f3pez","year":"2011","unstructured":"P\u00e9rez-L\u00f3pez M, et al. Retrobulbar ocular blood flow changes after orbital decompression in Graves\u2019 ophthalmopathy measured by color Doppler imaging. Invest Ophthalmol Vis Sci. 2011;52(8):5612\u20137.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"4","key":"3308_CR13","doi-asserted-by":"publisher","first-page":"2063","DOI":"10.1167\/iovs.16-21289","volume":"58","author":"M Al-Sheikh","year":"2017","unstructured":"Al-Sheikh M, et al. Quantitative OCT Angiography of the Retinal Microvasculature and the Choriocapillaris in Myopic Eyes. Invest Ophthalmol Vis Sci. 2017;58(4):2063\u20139.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"8","key":"3308_CR14","doi-asserted-by":"publisher","first-page":"e631","DOI":"10.1111\/j.1755-3768.2011.02236.x","volume":"89","author":"P Founti","year":"2011","unstructured":"Founti P, et al. Agreement among three examiners of colour Doppler imaging retrobulbar blood flow velocity measurements. Acta Ophthalmol. 2011;89(8):e631\u20134.","journal-title":"Acta Ophthalmol"},{"issue":"10","key":"3308_CR15","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1136\/bjophthalmol-2016-310056","volume":"101","author":"K Xue","year":"2017","unstructured":"Xue K, et al. Retrobulbar ocular blood flow changes measured by colour Doppler imaging after intra-arterial chemotherapy in retinoblastoma. Br J Ophthalmol. 2017;101(10):1419\u201322.","journal-title":"Br J Ophthalmol"},{"issue":"2","key":"3308_CR16","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/j.ecl.2021.12.004","volume":"51","author":"TD Hoang","year":"2022","unstructured":"Hoang TD, et al. 2022 Update on Clinical Management of Graves Disease and Thyroid Eye Disease. Endocrinol Metab Clin North Am. 2022;51(2):287\u2013304.","journal-title":"Endocrinol Metab Clin North Am"},{"issue":"2","key":"3308_CR17","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1007\/s42000-023-00437-7","volume":"22","author":"M Katahira","year":"2023","unstructured":"Katahira M, et al. Clinical significance of thyroglobulin antibodies and thyroid peroxidase antibodies in Graves\u2019 disease: a cross-sectional study. Hormones (Athens). 2023;22(2):253\u201361.","journal-title":"Hormones (Athens)"},{"issue":"2","key":"3308_CR18","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1007\/s12519-014-0476-y","volume":"10","author":"JH Lee","year":"2014","unstructured":"Lee JH, et al. Thyroid peroxidase antibody positivity and triiodothyronine levels are associated with pediatric Graves\u2019 ophthalmopathy. World J Pediatr. 2014;10(2):155\u20139.","journal-title":"World J Pediatr"},{"key":"3308_CR19","doi-asserted-by":"publisher","first-page":"1454616","DOI":"10.1155\/2018\/1454616","volume":"2018","author":"A Bruscolini","year":"2018","unstructured":"Bruscolini A, et al. Management of Patients with Graves\u2019 Disease and Orbital Involvement: Role of Spectral Domain Optical Coherence Tomography. J Immunol Res. 2018;2018:1454616.","journal-title":"J Immunol Res"},{"issue":"3","key":"3308_CR20","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1080\/02713683.2016.1198488","volume":"42","author":"S \u00c7al\u0131\u015fkan","year":"2017","unstructured":"\u00c7al\u0131\u015fkan S, Acar M, G\u00fcrdal C. Choroidal Thickness in Patients with Graves\u2019 Ophthalmopathy. Curr Eye Res. 2017;42(3):484\u201390.","journal-title":"Curr Eye Res"},{"issue":"5","key":"3308_CR21","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1016\/j.ajo.2008.12.008","volume":"147","author":"R Margolis","year":"2009","unstructured":"Margolis R, Spaide RF. A pilot study of enhanced depth imaging optical coherence tomography of the choroid in normal eyes. Am J Ophthalmol. 2009;147(5):811\u20135.","journal-title":"Am J Ophthalmol"},{"issue":"1","key":"3308_CR22","doi-asserted-by":"publisher","first-page":"e0146344","DOI":"10.1371\/journal.pone.0146344","volume":"11","author":"R Agrawal","year":"2016","unstructured":"Agrawal R, et al. Choroidal Vascularity Index (CVI)\u2013A Novel Optical Coherence Tomography Parameter for Monitoring Patients with Panuveitis? PLoS ONE. 2016;11(1):e0146344.","journal-title":"PLoS ONE"},{"key":"3308_CR23","doi-asserted-by":"crossref","unstructured":"Iovino, C., et al., Choroidal Vascularity Index: An In-Depth Analysis of This Novel Optical Coherence Tomography Parameter. J Clin Med, 2020. 9(2).","DOI":"10.3390\/jcm9020595"},{"key":"3308_CR24","doi-asserted-by":"publisher","first-page":"100829","DOI":"10.1016\/j.preteyeres.2020.100829","volume":"77","author":"R Agrawal","year":"2020","unstructured":"Agrawal R, et al. Exploring choroidal angioarchitecture in health and disease using choroidal vascularity index. Prog Retin Eye Res. 2020;77:100829.","journal-title":"Prog Retin Eye Res"},{"issue":"1","key":"3308_CR25","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/s40662-021-00242-6","volume":"8","author":"P Loiudice","year":"2021","unstructured":"Loiudice P, et al. Choroidal vascularity index in thyroid-associated ophthalmopathy: a cross-sectional study. Eye Vis (Lond). 2021;8(1):18.","journal-title":"Eye Vis (Lond)"},{"key":"3308_CR26","doi-asserted-by":"crossref","unstructured":"Yeter V, et al. Choroidal vascularity index in thyroid-associated ophthalmopathy. Can J Ophthalmol. 2023;58(1):27-33.","DOI":"10.1016\/j.jcjo.2021.06.023"},{"issue":"1","key":"3308_CR27","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1136\/bjophthalmol-2015-307399","volume":"100","author":"JJ Khong","year":"2016","unstructured":"Khong JJ, et al. Pathogenesis of thyroid eye disease: review and update on molecular mechanisms. Br J Ophthalmol. 2016;100(1):142\u201350.","journal-title":"Br J Ophthalmol"},{"issue":"2","key":"3308_CR28","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.preteyeres.2009.12.002","volume":"29","author":"DL Nickla","year":"2010","unstructured":"Nickla DL, Wallman J. The multifunctional choroid. Prog Retin Eye Res. 2010;29(2):144\u201368.","journal-title":"Prog Retin Eye Res"},{"issue":"10","key":"3308_CR29","doi-asserted-by":"publisher","first-page":"585","DOI":"10.2176\/nmc.ra.2015-0324","volume":"56","author":"N Toma","year":"2016","unstructured":"Toma N. Anatomy of the Ophthalmic Artery: Embryological Consideration. Neurol Med Chir (Tokyo). 2016;56(10):585\u201391.","journal-title":"Neurol Med Chir (Tokyo)"},{"issue":"9","key":"3308_CR30","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1136\/bjo.84.9.1027","volume":"84","author":"MN Alp","year":"2000","unstructured":"Alp MN, et al. Colour Doppler imaging of the orbital vasculature in Graves\u2019 disease with computed tomographic correlation. Br J Ophthalmol. 2000;84(9):1027\u201330.","journal-title":"Br J Ophthalmol"},{"issue":"6","key":"3308_CR31","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1080\/01676830.2018.1556704","volume":"38","author":"M Jamshidian-Tehrani","year":"2019","unstructured":"Jamshidian-Tehrani M, et al. Color Doppler imaging in thyroid eye disease and its correlation to disease activity. Orbit. 2019;38(6):440\u20135.","journal-title":"Orbit"},{"key":"3308_CR32","doi-asserted-by":"publisher","first-page":"707","DOI":"10.3389\/fendo.2019.00707","volume":"10","author":"D Walasik-Szempli\u0144ska","year":"2019","unstructured":"Walasik-Szempli\u0144ska D, et al. A Comparison of Doppler Flow Parameters in the Ophthalmic Artery and Central Retinal Artery in Patients With Graves\u2019 Disease and Toxic Nodular Goiter. Front Endocrinol (Lausanne). 2019;10:707.","journal-title":"Front Endocrinol (Lausanne)"}],"container-title":["BMC Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12886-024-03308-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12886-024-03308-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12886-024-03308-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,13]],"date-time":"2024-02-13T09:06:27Z","timestamp":1707815187000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcophthalmol.biomedcentral.com\/articles\/10.1186\/s12886-024-03308-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,13]]},"references-count":32,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["3308"],"URL":"https:\/\/doi.org\/10.1186\/s12886-024-03308-w","relation":{},"ISSN":["1471-2415"],"issn-type":[{"value":"1471-2415","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,2,13]]},"assertion":[{"value":"5 April 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 January 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 February 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Ethics Committee of the Nanjing Drum Tower Hospital and was performed in accordance with the Declaration of Helsinki. Informed consent was obtained from the participants.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"64"}}